DonnaDCarstensMD

Pulmonology • Philadelphia, PA

Critical Care Medicine

Physician

Join to view full profile

Dr. Carstens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Carstens' full profile

Already have an account?

Office
1015 Chestnut St
Suite 1300
Philadelphia, PA 19107
Phone+1 215-923-7685

Fax+1 215-923-8230

Education & Training

Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
Duke University HospitalResidency, Internal Medicine, 1990 - 1993
McGill University Faculty of MedicineClass of 1990

Certifications & Licensure

PA State Medical License 2000 - 2024
NC State Medical License 1993 - 2001

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013

Publications & Presentations

PubMed

Real-World Effectiveness of Benralizumab Among Patients with Asthma and Concomitant Chronic Obstructive Pulmonary Disease.
Donna D Carstens, Diego J Maselli, Erin E Cook, Fan Mu, Jingyi Chen
International Journal of Chronic Obstructive Pulmonary Disease. 2024-01-01
4 citations
Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE.
Reynold A Panettieri Jr, Njira Lugogo, Wendy C Moore, Bradley E Chipps, Brett Jepson
Respiratory Medicine. 2023-09-01
2 citations
The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
Eduardo Genofre, Donna Carstens, Wilfried DeBacker, Patrick Muchmore, Reynold A Panettieri Jr
Respiratory Research. 2023-05-03

Press Mentions

Real-World Study Extends Benralizumab Asthma BenefitJune 11th, 2023
Real-World Study Extends Benralizumab Asthma BenefitJune 11th, 2023